Oura’s Menopause Impact Scale Expands Out of the App and Into Women’s Health Care
The creator of the Oura Ring is partnering with women’s health companies in the name of menopause.
The Menopause Impact Scale (MIS) from Oura, a wearable health technology company, is expanding beyond its app and now integrates with various women's health care providers. This new development aims to standardize menopause symptom assessment for women, as the stage remains stigmatized and poorly studied. The MIS, created by Oura's science and clinical teams, gauges the impact of 22 symptoms across seven domains over a two-week period, assigning a score from 0 to 4 for each domain.
The total impact score ranges from 0 to 28, with categories ranging from minimal to high impact. Over 600,000 Oura members have taken the MIS, with 35% completing it multiple times. Starting this week, MIS results can be integrated with ten partners, including Alloy Health, Gennev, Wisp, Maven, Tia, Xella, Oova, Mira, and Hertility.
The transition to menopause generally spans seven to 14 years, and the MIS can help track symptom trends. Users require an Oura Ring and an Oura subscription to access the MIS, which costs $6 per month or $72 per year. Despite potential drawbacks, such as increased commercialization, the integration of menopause-focused femtech may lead to more open conversations about women's health in medical settings.
Written by urgent.news from CNET's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
